Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 179 results found. Search for [ mRNA COVID-19 vaccine ]

Results 1 to 21 of 179
Reuters
June 24, 2021
The estimate is included in a report, which is to be discussed on Thursday at a board meeting of Gavi, a vaccine alliance that co-leads the WHO's Covid-19 vaccine programme COVAX


BusinessToday.In
June 22, 2021
Pfizer is holding talks with the Indian government for supplying its COVID-19 vaccine to the country. Pfizer's COVID-19 vaccine may be priced under $10 (around Rs 730) per dose in India


Associated Press
June 11, 2021
At the G7 Summit I hope my fellow leaders will make similar pledges so that, together, we can vaccinate the world by the end of next year and build back better from coronavirus, Johnson said in a statement


BusinessToday.In
June 10, 2021
The Pfizer-BioNTech coronavirus vaccine costs $19.5 (Rs 1,423) per dose in the US, and around $21 (Rs 1,532) a dose in the UK


Reuters
June 9, 2021
The study will enroll up to 4,500 children at more than 90 clinical sites in the United States, Finland, Poland and Spain, the company said


Associated Press
June 3, 2021
The US has said it plans to share 80 million vaccine doses globally by the end of June. The administration says 25% will be kept in reserve for emergencies and for the U.S. to share directly with allies and partners


BusinessToday.In
June 3, 2021
The self-test kit can be bought at drug stores and chemist shops in 2-3 days. Individuals can also order it online through e-commerce giant Flipkart


PTI
June 3, 2021
Relaxation of restrictions as per the situation in different areas is only under consideration and no decision has been taken, a statement from the Chief Minister's Office (CMO) said


PTI
June 3, 2021
It has been decided to extend the restrictions by a week following the recommendation of experts till June 14 morning, CM Yediyurappa told a press conference


BusinessToday.In
June 3, 2021
The Union Health Ministry will make an advance payment of Rs 1,500 crore to Hyderabad-based drugmaker Biological-E for what will be the second made-in-India vaccine following Bharat Biotech's Covaxin


PB Jayakumar
June 2, 2021
The acquisition of Akorn India helped Biological E create a potential overall manufacturing capacity of over 1 billion doses per annum.


Reuters
June 2, 2021
The Chumakov Centre could produce six times more than the previously planned 10 million doses of the vaccine a year


Reuters
June 2, 2021
Biden on Monday said his administration will send at least 20 million doses of the Pfizer-BioNTech, Moderna and Johnson & Johnson vaccines, on top of 60 million AstraZeneca doses he had already planned to give to other countries


Reuters
June 1, 2021
Biological E. will run a clinical trial of Providence's vaccine in India and seek emergency use approval for it, the company said in a statement


PTI
June 1, 2021
Cipla has said such an assurance will help make this significant financial commitment of more than $1 billion (over Rs 7,250 crore) advance to Moderna for its booster vaccine in India


BusinessToday.In
May 31, 2021
According to Chairman of COVID-19 working group under National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora, work is expected to begin 'in a few weeks'


Manoj Sharma
May 17, 2021
The current vaccine makers, Serum Institute and Bharat Biotech, alone won't be able to meet the demand. There are other players too in vaccine production, and they should be able to cater to the demand in the months ahead


PTI
May 16, 2021
Moderna has been widely used in countries such as Canada, United States and the United Kingdom under emergency use authorisations granted by these countries and the World Health Organisation.


Associated Press
May 11, 2021
Ramaphosa's message reflects his country's hope that the waiver, first proposed by South Africa and India, may still happen despite opposition from nations like Germany


Reuters
May 10, 2021
Based on these delivery contracts, the firm said it expects about 12.4 billion euros ($15.1 billion) in revenues from the product this year, including sales, milestone payments from partners and a share of gross profit in the partners' territories


PAGES 1 OF 9  12345